Allergy Therapeutics PLC (AIM:AGY, OTC:AGYTF) says its top-dose peanut allergy treatment has proved safe, hitting the key goal in early testing. The trial is now moving to unblinded skin prick tests as it builds towards a Phase IIb study. Read more
Scancell Holdings PLC (AIM:SCLP, OTC:SCNLF) has reported more positive data for its melanoma vaccine iSCIB1+, showing 74% progression-free survival at 16 months. The company is preparing for late-stage trials next year after strong responses across tough-to-treat patient groups. Watch more
IXICO PLC (LSE:IXI, OTC:PHYOF) has lifted its order book to £17.7 million following the end of its 2025 financial year, thanks to a run of new neuroscience contracts. The group says interest in imaging and biomarker tools is growing, supporting a confident outlook for 2026. Watch more
Ariana Resources PLC (AIM:AAU, ASX:AA2) has agreed a funding term sheet that will inject A$8 million into its Dokwe gold project in Zimbabwe. The deal brings in partner Xinhai and moves the project a step closer to feasibility and future production. Read more
Follow us and subscribe on YouTube, our social channels and on proactiveinvestors.co.uk.